Interestingly, in the FNDC4-treated group, colitis severity was significantly ameliorated, as demonstrated by a lower disease activity index (DAI)12 score (Fig. 4a), and a reduced shortening of the colon length, a surrogate marker for the degree of inflammation in the DSS model (Fig. 4b). Here, FNDC4 is linked to colitis.